Top News – Chesapeake (NYSE:CHK) , Tesla (NASDAQ:TSLA) , Federal Signal (NYSE:FSS) , Cara Therapeutics (NASDAQ:CARA) , Bankwell Financial (NASDAQ:BWFG)

Chesapeake Energy (NYSE:CHK)’s stock had its “hold” rating restated by stock analysts at Deutsche Bank in a report issued on Friday. They currently have a $33.00 price objective on the stock, up from their previous price objective of $31.00. Deutsche Bank’s target price indicates a potential upside of 22.22% from the company’s current price. Chesapeake Energy Corporation (NYSE:CHK) stock performance was 0.67% in last session and finished the day at $27.00. Traded volume was 5.94million shares in the last session and the average volume of the stock remained 8.97million shares. The beta of the stock remained 1.22. Chesapeake Energy Corporation (NYSE:CHK) insider ownership is %.

Tesla Motors Inc (NASDAQ:TSLA) has successfully fought for the right to sell its vehicles in many states throughout the country, however, it has come up short in others. Tesla Motors Inc (NASDAQ:TSLA) rose 2.14 percent to $220.02 Friday on volume of 4.26million shares. The intra-day range of the stock was $215.93 to $221.21. Tesla Motors Inc (NASDAQ:TSLA) has a market capitalization of $27.30billion.

Federal Signal Corporation (NYSE:FSS), a leader in environmental and safety solutions, will announce second quarter earnings before the market opens on Tuesday, July 29, 2014.  The Company will also host an investor conference call and webcast at 10 a.m. Eastern Time the same day with Dennis J. Martin, president and CEO, Brian S. Cooper, chief financial officer, and Jennifer L. Sherman, chief operating officer. Federal Signal Corporation (NYSE:FSS)’s stock on July 18, 2014 reported a increase of 14.26% to the closing price of $14.26. Its fifty two weeks range is $9.26 -$16.05. The total market capitalization recorded $896.65million. The overall volume in the last trading session was 184,419.00million shares. In its share capital, FSS has 62.88million outstanding shares.

Cara Therapeutics Inc (NASDAQ:CARA) announced that Dr. Robert Medve has been named Chief Medical Officer. On Friday, shares of Cara Therapeutics Inc (NASDAQ:CARA) advanced 3.45% to close the day at $13.51. Company return on investment (ROI) is 0.40% and its monthly performance is recorded as -3.57%. Cara Therapeutics Inc (NASDAQ:CARA) quarterly revenue growth is 0.97%.

On 23 JUNE Bankwell Financial Group, Inc. (NASDAQ:BWFG) had issued 2,702,703 shares in its IPO .The total size of the offering was $48,648,654 based on an initial share price of $18.00. During the company’s quiet period, insiders and any underwriters involved in the IPO are restricted from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission.  Bankwell Financial Group Inc (NASDAQ:BWFG) stock finished the day at $17.14. Traded volume was 65.00million shares in the last session and the average volume of the stock remained 21.44K shares. The beta of the stock remained 1.10. Bankwell Financial Group Inc (NASDAQ:BWFG) insider ownership is 26.80%.